日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Antimicrobial Activity Profiles and Potential Antimicrobial Regimens against Carbapenem-Resistant Enterobacterales Isolated from Multi-Centers in Western Thailand

泰国西部多中心分离的耐碳青霉烯类肠杆菌的抗菌活性谱及潜在抗菌方案

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics11030355
Nulsopapon, Parnrada; Pongchaidecha, Manat; Nasomsong, Worapong; Polwichai, Pitimon; Suphankong, Sirilada; Sirichote, Pantip; Chaisomboonpan, Siriwan; Santimaleeworagun, Wichai
发表日期：2022
文献求助 收藏

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant Pseudomonas aeruginosa

优化头孢洛扎/他唑巴坦单药治疗或与阿米卡星联合治疗耐碳青霉烯类铜绿假单胞菌感染的剂量

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics11040517
Nasomsong, Worapong; Nulsopapon, Parnrada; Changpradub, Dhitiwat; Pungcharoenkijkul, Supanun; Hanyanunt, Patomroek; Chatreewattanakul, Tassanawan; Santimaleeworagun, Wichai
炎症/感染
发表日期：2022
文献求助 收藏

Correction: Nulsopapon et al. The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates. Antibiotics 2021, 10, 736

更正：Nulsopapon 等人，《替加环素与氨基糖苷类抗生素联合治疗临床耐碳青霉烯类肺炎克雷伯菌分离株的协同活性及剂量优化》，《抗生素》2021, 10, 736

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics11060745
Nulsopapon, Parnrada; Nasomsong, Worapong; Pongchaidecha, Manat; Changpradub, Dhitiwat; Juntanawiwat, Piraporn; Santimaleeworagun, Wichai
肺炎
发表日期：2022
文献求助 收藏

The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital

头孢他啶-阿维巴坦在泰国某大学医院治疗携带不同碳青霉烯酶类型的耐碳青霉烯类肺炎克雷伯菌临床分离株的潜在应用

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S321147
Nasomsong, Worapong; Nulsopapon, Parnrada; Changpradub, Dhitiwat; Pongchaidecha, Manat; Pungcharoenkijkul, Supanun; Juntanawiwat, Piraporn; Simsiriporn, Waristha; Santimaleeworagun, Wichai
肺炎
发表日期：2021
文献求助 收藏

The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant Klebsiella pneumoniae Isolates

替加环素联合氨基糖苷类抗生素对临床分离的耐碳青霉烯类肺炎克雷伯菌的协同作用及剂量优化

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics10060736
Nulsopapon, Parnrada; Nasomsong, Worapong; Pongchaidecha, Manat; Changpradub, Dhitiwat; Juntanawiwat, Piraporn; Santimaleeworagun, Wichai
肺炎
发表日期：2021
文献求助 收藏

Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?

粘菌素联合舒巴坦或磷霉素治疗耐碳青霉烯类鲍曼不动杆菌：疗效提高还是肾毒性风险降低？

期刊:Infection and Chemotherapy
影响因子:2.9
doi:10.3947/ic.2021.0007
Saelim, Weerayuth; Changpradub, Dhitiwat; Thunyaharn, Sudaluck; Juntanawiwat, Piraporn; Nulsopapon, Parnrada; Santimaleeworagun, Wichai
毒理研究
发表日期：2021
文献求助 收藏